Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease

被引:53
作者
Man, WDC
Hopkinson, NS
Harraf, F
Nikoletou, D
Polkey, MI
Moxham, J
机构
[1] Kings Coll Hosp London, Guys Kings & St Thomas Sch Med, Resp Muscle Lab, London SE5 9PJ, England
[2] Royal Brompton Hosp, London SW3 6LY, England
基金
英国惠康基金;
关键词
D O I
10.1136/thx.2005.040709
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Quadriceps muscle weakness is common in chronic obstructive pulmonary disease ( COPD) but is not observed in a small hand muscle ( adductor pollicis). Although this could be explained by reduced activity in the quadriceps, the observation could also be explained by anatomical location of the muscle or fibre type composition. However, the abdominal muscles are of a similar anatomical and fibre type distribution to the quadriceps, although they remain active in COPD. Cough gastric pressure is a recently described technique that assesses abdominal muscle ( and hence expiratory muscle) strength more accurately than traditional techniques. A study was undertaken to test the hypothesis that more severe weakness exists in the quadriceps than in the abdominal muscles of patients with COPD compared with healthy elderly controls. Methods: Maximum cough gastric pressure and quadriceps isometric strength were measured in 43 patients with stable COPD and 25 healthy elderly volunteers matched for anthropometric variables. Results: Despite a significant reduction in mean quadriceps strength (29.9 kg v 41.2 kg; 95% CI -17.9 to 24.6; p = 0.001), cough gastric pressure was preserved in patients with COPD (227.3 cm H2O v 204.8 cm H2O; 95% CI -5.4 to 50.6; p = 0.11). Conclusions: Abdominal muscle strength is preserved in stable COPD outpatients in the presence of quadriceps weakness. This suggests that anatomical location and fibre type cannot explain quadriceps weakness in COPD. By inference, we conclude that disuse and consequent deconditioning are important factors in the development of quadriceps muscle weakness in COPD patients, or that activity protects the abdominal muscles from possible systemic myopathic processes.
引用
收藏
页码:718 / 722
页数:5
相关论文
共 38 条
[21]   Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD [J].
Man, WDC ;
Mustfa, N ;
Nikoletou, D ;
Kaul, S ;
Hart, N ;
Rafferty, GF ;
Donaldson, N ;
Polkey, MI ;
Moxham, J .
THORAX, 2004, 59 (06) :471-476
[22]   Cough gastric pressure and maximum expiratory mouth pressure in humans [J].
Man, WDC ;
Kyroussis, D ;
Fleming, TA ;
Chetta, A ;
Harraf, F ;
Mustfa, N ;
Rafferty, GF ;
Polkey, MI ;
Moxham, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (06) :714-717
[23]   Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease [J].
Man, WDC ;
Soliman, MGG ;
Nikoletou, D ;
Harris, ML ;
Rafferty, GF ;
Mustfa, N ;
Polkey, MI ;
Moxham, J .
THORAX, 2003, 58 (08) :665-669
[24]   Pulmonary emphysema decreases hamster skeletal muscle oxidative enzyme capacity [J].
Mattson, JP ;
Poole, DC .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (01) :210-214
[25]   ABDOMINAL MUSCLE USE DURING BREATHING IN PATIENTS WITH CHRONIC AIR-FLOW OBSTRUCTION [J].
NINANE, V ;
RYPENS, F ;
YERNAULT, JC ;
DETROYER, A .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (01) :16-21
[26]   RELATIONSHIP BETWEEN RESPIRATORY MUSCLE STRENGTH AND LEAN BODY-MASS IN MEN WITH COPD [J].
NISHIMURA, Y ;
TSUTSUMI, M ;
NAKATA, H ;
TSUNENARI, T ;
MAEDA, H ;
YOKOYAMA, M .
CHEST, 1995, 107 (05) :1232-1236
[27]   Nutritional status and muscle strength in patients with emphysema and severe α1-antitrypsin deficiency [J].
Piitulainen, E ;
Areberg, J ;
Lindén, M ;
Eriksson, S ;
Mattsson, S ;
Wollmer, P .
CHEST, 2002, 122 (04) :1240-1246
[28]  
Polkey MI, 1996, MUSCLE NERVE, V19, P549, DOI 10.1002/(SICI)1097-4598(199605)19:5<549::AID-MUS1>3.0.CO
[29]  
2-B
[30]   Functional magnetic stimulation of the abdominal muscles in humans [J].
Polkey, MI ;
Luo, YM ;
Guleria, R ;
Hamnegård, CH ;
Green, M ;
Moxham, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :513-522